BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Go EJ, Yang H, Chon HJ, Yang D, Ryu W, Kim DH, Han DK, Kim C, Park W. Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy. Cancers (Basel). 2020;12. [PMID: 33114476 DOI: 10.3390/cancers12113123] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Han J, Lee YY, Shin HE, Han J, Kang JM, James Wang C, Park J, Kim S, Yoon J, Kwon H, Park D, Park T, Choy YB, Kim D, Kim T, Min J, Kim I, Park CG, Han DK, Park W. Image-guided in situ cancer vaccination with combination of multi-functional nano-adjuvant and an irreversible electroporation technique. Biomaterials 2022;289:121762. [DOI: 10.1016/j.biomaterials.2022.121762] [Reference Citation Analysis]
2 Wang Y, Jiang T, Xie L, Wang H, Zhao J, Xu L, Fang C. Effect of pulsed field ablation on solid tumor cells and microenvironment. Front Oncol 2022;12:899722. [DOI: 10.3389/fonc.2022.899722] [Reference Citation Analysis]
3 Justesen TF, Orhan A, Raskov H, Nolsoe C, Gögenur I. Electroporation and Immunotherapy-Unleashing the Abscopal Effect. Cancers (Basel) 2022;14:2876. [PMID: 35740542 DOI: 10.3390/cancers14122876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ma Z, Wong S, Forgham H, Esser L, Lai M, Leiske M, Kempe K, Sharbeen G, Youkhana J, Mansfeld F, Quinn J, Phillips P, Davis T, Kavallaris M, Mccarroll J. Aerosol delivery of star polymer-siRNA nanoparticles as a therapeutic strategy to inhibit lung tumor growth. Biomaterials 2022;285:121539. [DOI: 10.1016/j.biomaterials.2022.121539] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Han J, Shin HE, Lee J, Kang JM, Park J, Park CG, Han DK, Kim I, Park W. Combination of Metal‐Phenolic Network‐Based Immunoactive Nanoparticles and Bipolar Irreversible Electroporation for Effective Cancer Immunotherapy. Small. [DOI: 10.1002/smll.202200316] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Senders ZJ, Martin RCG 2nd. Intratumoral Immunotherapy and Tumor Ablation: A Local Approach with Broad Potential. Cancers (Basel) 2022;14:1754. [PMID: 35406525 DOI: 10.3390/cancers14071754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang D, Dong R, Wang X, Jiang X. Flexible Electronic Catheter Based on Nanofibers for the In Vivo Elimination of Circulating Tumor Cells. ACS Nano 2022. [PMID: 35302351 DOI: 10.1021/acsnano.1c09807] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yin M, Hu J, Yuan Z, Luo G, Yao J, Wang R, Liu D, Cao B, Wu W, Hu Z. STING agonist enhances the efficacy of programmed death-ligand 1 monoclonal antibody in breast cancer immunotherapy by activating the interferon-β signalling pathway. Cell Cycle 2022;:1-13. [PMID: 35130108 DOI: 10.1080/15384101.2022.2029996] [Reference Citation Analysis]
9 Kim JH, Lee WS, Lee HJ, Yang H, Lee SJ, Kong SJ, Je S, Yang HJ, Jung J, Cheon J, Kang B, Chon HJ, Kim C. Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway. Oncoimmunology 2021;10:2005280. [PMID: 34858729 DOI: 10.1080/2162402X.2021.2005280] [Reference Citation Analysis]
10 Kim CW, Chon HJ, Kim C. Combination Immunotherapies to Overcome Intrinsic Resistance to Checkpoint Blockade in Microsatellite Stable Colorectal Cancer. Cancers (Basel) 2021;13:4906. [PMID: 34638390 DOI: 10.3390/cancers13194906] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Oikonomou D, Karamouzis MV, Moris D, Dimitrokallis N, Papamichael D, Kountourakis P, Astras G, Davakis S, Papalampros A, Schizas D, Petrou AS, Felekouras E. Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC). Am J Clin Oncol 2021;44:325-30. [PMID: 33979098 DOI: 10.1097/COC.0000000000000826] [Reference Citation Analysis]
12 Eresen A, Yang J, Scotti A, Cai K, Yaghmai V, Zhang Z. Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma. Ann Transl Med 2021;9:1089. [PMID: 34423001 DOI: 10.21037/atm-21-539] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Bibok A, Kim DW, Malafa M, Kis B. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer. World J Gastroenterol 2021; 27(27): 4322-4341 [PMID: 34366607 DOI: 10.3748/wjg.v27.i27.4322] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Alinezhadbalalami N, Graybill PM, Imran KM, Verbridge SS, Allen IC, Davalos RV. Generation of Tumor-activated T cells using electroporation. Bioelectrochemistry 2021;142:107886. [PMID: 34303065 DOI: 10.1016/j.bioelechem.2021.107886] [Reference Citation Analysis]
15 Burbach BJ, O'Flanagan SD, Shao Q, Young KM, Slaughter JR, Rollins MR, Street TJL, Granger VE, Beura LK, Azarin SM, Ramadhyani S, Forsyth BR, Bischof JC, Shimizu Y. Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells. Nat Commun 2021;12:3862. [PMID: 34162858 DOI: 10.1038/s41467-021-24132-6] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
16 Zou SS, Qiao Y, Zhu S, Gao B, Yang N, Liu YJ, Chen J. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them. Pharmacol Res 2021;166:105514. [PMID: 33631336 DOI: 10.1016/j.phrs.2021.105514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]